A family of institutions
working together on the Can Ruti Campus
 

News

The Clinical and Environmental Infectious Diseases Research Group signs a collaboration for the development of a new biocide for the treatment of drinking water

The Clinical and Environmental Infectious Diseases Research Group (CEID) has discovered a molecule of natural origin with a high bactericidal, amoebicidal and biofilm reduction capacity. The collaboration signed by the group's researchers with a private company will finance the improvement of the molecule's characteristics to be applied in large water installations, preventing water for human consumption from acting as a vehicle for the transmission of bacterial diseases.

14/03/2023 - Research

Breaking barriers in hepatitis C diagnosis and treatment for populations at risk

A study with people who inject drugs evaluated a minimally invasive test based on dried blood spots (DBS) for the monitoring of hepatitis C virus (HCV) infection. The use of DBS samples for HCV RNA detection and genotyping was shown to effectively assess cure after treatment and to differentiate between reinfection and treatment failure. The results support the viability of decentralizing treatment and post-treatment monitoring for people who inject drugs, who frequently face challenges accessing the healthcare system. The study has been published in the Journal of Medical Virology.

Events

The IGTP in numbers

  • 795

    Contracted and seconded research staff

  • 289

    Active projects

  • 1022

    Publications

  • 36

    Active patent families

  • 657

    Active clinical trials

  • 18

    Transferred patents

  • 7

    Spin-Offs

The IGTP is an accredited centre of Excellence of the Instituto de Salud Carlos III (Spanish Government)

Instituto de Salud Carlos III


The IGTP is a member of


Governance


With the support of


Accreditation

  • HR Excellence in Research